Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 53330-94-2 | MDL No. : | MFCD00481875 |
Formula : | C10H9NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GOFIUEUUROFVMA-UHFFFAOYSA-N |
M.W : | 159.19 | Pubchem ID : | 40732 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.1 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 48.49 |
TPSA : | 32.86 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.52 cm/s |
Log Po/w (iLOGP) : | 1.51 |
Log Po/w (XLOGP3) : | 1.06 |
Log Po/w (WLOGP) : | 2.37 |
Log Po/w (MLOGP) : | 1.18 |
Log Po/w (SILICOS-IT) : | 2.85 |
Consensus Log Po/w : | 1.79 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.98 |
Solubility : | 1.65 mg/ml ; 0.0104 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.34 |
Solubility : | 7.26 mg/ml ; 0.0456 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.61 |
Solubility : | 0.0393 mg/ml ; 0.000247 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.07 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72.9% | at 0 - 20℃; Inert atmosphere | To a solution of indole-5-acid (2.5 g, 15.5 mmol) in 30 mL anhydrous THF, a solution of CH3Li (1.6 M, 30 mL, 51.2 mmol) in diethyl ether was added dropwise at 0 °C under N2 atmosphere. The mixture was stirred at room temperature for 4 h, the reaction was quenched by NH4Cl aqueous, and extracted with CH2Cl2 (3 * 50 mL). The combined organic layers were then washed with brine, dried over anhydrous Na2SO4, and concentrated in vacuo to provide 1.8 g 5-acetylindole (24) as white solid. |
50.6% | Stage #1: at 20℃; for 41 h; Stage #2: With water In tetrahydrofuran; diethyl ether at 0℃; |
To a solution of indole-5-carboxylic acid [10G, 62.05 mmol, Intermediate (16) ] in anhydrous tetrahydrofuran (1000 mL) is added methyl lithium (1.6M in diethyl ether, 150 mL) drop wise over 60 minutes periods. The resulting precipitate is stirred at ambient temp for 40 hours. The reaction is cooled to 0°C and quenched by the cautious addition of water (5 ML) until boiling stopped. The solvent is removed in vacuo and the slurry mixture is partitioned between dichloromethane (500 ML) and water (100 mL). Dichloromethane layer is washed with 1N hydrochloric acid (20 mL), saturated NAHC03 (20 ML), brine and dried over sodium sulfate. The residue is chromatographed on 110 g silica gel cartridge (30 to 50percent ethyl acetate gradient in heptane) to afford L- (LH-INDOL-5-Y)-ETHANONE [5. 0G, 50.6percent, Intermediate (17) ] as colorless oil. Oil solidified on standing; 1H NMR (CDC13) : 8 8.846 (1H, br s), 8.356 (1H, s), 7.917 (1H, d), 7.449-7. 297 (2H, m), 6.690 (1H), 2.713 (3H, s); LC/MS : 160 (M + H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
323 mg | at 20 - 50℃; for 1 h; | [001241j Step B: The crude product from Step A was dissolved in THF (20 mL). A 1.4 M solution of methylmagnesium bromide (11.2 mL, 15.6 mmol) in THF:toluene (3:1), was added drop wise to the solution. The solution was allowed to warm to room temperature. The solution was stirred at 50 °C for 1 hour, upon which iN aqueous HC1 (50 mL) was slowly added. The mixture was partitioned into EtOAc (200 mL) and aqueous iN NaOH (200 mL). The organic layer was washed with brine, dried over Na2504, filtered and concentrated. The residue was chromatographed on silica, eluting with EtOAc (0percent to 50percent) in hexanes to afford 1-(1H-indol-5- yl)ethanone as a white powder (323 mg, 33percent). |
[ 1484-04-4 ]
1-(9-Ethyl-9H-carbazol-3-yl)ethanone
Similarity: 0.92
[ 23699-65-2 ]
1-(3-(Phenylamino)phenyl)ethanone
Similarity: 0.91
[ 23600-83-1 ]
1-(4-(Phenylamino)phenyl)ethanone
Similarity: 0.89
[ 5416-80-8 ]
2-Methyl-1H-indole-3-carbaldehyde
Similarity: 0.88